(Q38014542)

27 August 2017

title

Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research (English)

1 reference

27 August 2017

1 reference

1 reference

Ute Schütte

1

1 reference

27 August 2017

Savita Bisht

series ordinal

2

1 reference

27 August 2017

Peter Brossart

series ordinal

3

1 reference

27 August 2017

Georg Feldmann

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

19 November 2010

1 reference

Expert Opinion on Drug Discovery

27 August 2017

published in

1 reference

27 August 2017

volume

6

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

33-48

1 reference

27 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

In vitro models of pancreatic cancer for translational oncology research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Allele-specific expression in the germline of patients with familial pancreatic cancer: an unbiased approach to cancer gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Use of nude mouse xenograft models in prostate cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Potential of the scid mouse as a host for human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Tumor-stroma interactions in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

In vivo and in vitro propagation of intraductal papillary mucinous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Development of the transgenic cyan fluorescent protein (CFP)-expressing nude mouse for "Technicolor" cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

A low molecular weight PSMA-based fluorescent imaging agent for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Molecular imaging of metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

The use of targeted mouse models for preclinical testing of novel cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Pancreatic tumor pathogenesis reflects the causative genetic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Elastase I promoter directs expression of human growth hormone and SV40 T antigen genes to pancreatic acinar cells in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

TGF alpha transgenic mice. A model of pancreatic cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Trp53 deletion stimulates the formation of metastatic pancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Signal transduction--directed cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Insulin-promoter-factor 1 is required for pancreas development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

LKB1 regulates pancreatic beta cell size, polarity, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Hedgehog/Ras interactions regulate early stages of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Targets, trials, and travails in pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Targeting Notch signaling in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Elucidation of a universal size-control mechanism in Drosophila and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Immunotherapy for pancreatic cancer - science driving clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Mouse models of pancreatic cancer: the fur is finally flying!

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Finding the tumor copycat. Therapy fails, patients don't

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Finding the tumor copycat: approximating a human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Successful xenografting of cryopreserved primary pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

RAS unplugged: Negative feedback and oncogene-induced senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

Specific expression of an elastase–human growth hormone fusion gene in pancreatic acinar cells of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2011.534453

10.1517/17460441.2011.534453

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference